Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture

Highland Hospital, Rochester

University of Pennsylvania Health System-Presbyterian Medical Center, Philadelphia

Saint Joseph Medical Center, West Reading

University of Maryland School of Medicine, Baltimore

Danville Regional Medical Center, Danville

University of North Carolina Hospital, Chapel Hill

Duke University Health System, Durham

Palmetto Richland Memorial Hospital, Columbia

Atlanta Resarch Center, Decatur

United Osteoporosis Center Health Services, Gainesville

Radiant Research Lake Worth, Lake Worth

University of Alabama Hospital, Birmingham

Ohio State University, Columbus

University Orthopaedics, Canfield

Wayne State University, Div. of Endocrinology, Detroit

Mercy Arthritis and Osteoporosis Center, Des Moines

University of Wisconsin Hospital and Clinics, Madison

Health East Osteoporosis Service, Woodbury

Illinois Bone and Joint Institute, Morton Grove

Galesburg Orthopedic Services LTD, Galesburg

St. Luke's Episcopal Hospital, Houston

Seton Medical Center, Austin

Sharp Grossmont Hosptial, La Mesa

The Permanente Group, Santa Rosa

Osteoporosis Diagnostic Center, Eureka

Maine Medical Center Research Institute, Portland

Saint Josephs, Warwick

Novartis, Nuremberg